Retrospective Analysis of Treatment Patterns in Pseudophakic Diabetic Macular Oedema Eyes Treated with Anti-VEGF

Figure 2

Best-recorded visual acuity at baseline and after 6 intravitreal anti-VEGF injections. Notes: the solid line represents the 45-degree line, and the dashed line represents a 0.1 logMAR (5 letters) change from the 45-degree line following treatment. Mean baseline BRVA was 0.55 ± 0.27 logMAR (mean ± SD), and there was a nonsignificant improvement () to 0.52 ± 0.30 logMAR after anti-VEGF treatment. Black filled bars show BRVA ≤0.3 logMAR, open bars >0.03 and ≤ 0.6 logMAR, and grey filled bars >0.06 logMAR.